Compare Exelixis Inc. Common Stock (EXEL) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Exelixis Inc. Common Stock vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Exelixis Inc. Common Stock trades at $60.33 (market cap $14.62B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.84 (market cap $6.04B). The key difference: Exelixis Inc. Common Stock is far larger — about 2.4× Iovance Biotherapeutics Inc. Common Stock's market cap, and Iovance Biotherapeutics Inc. Common Stock is more actively traded (14,805,993 versus 2,684,957). Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 1 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| EXEL | IOVA | |
|---|---|---|
Market Cap | $14.62B | $6.04B |
Volume | 2,684,957 | 14,805,993 |
Sector | Health | Health |
52-Week High | $59.13 | $14.82 |
52-Week Low | $34.54 | $1.81 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $13.95B | $5.97B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Exelixis Inc. Common Stock
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
